Bratton Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-448,035
| Closed | -$16.1M | – | 2 |
|
|
2020
Q3 | $16.1M | Hold |
448,035
| – | – | 22.33% | 2 |
|
|
2020
Q2 | $10.8M | Sell |
448,035
-505,000
| -53% | -$12.2M | 16.23% | 2 |
|
|
2020
Q1 | $16.7M | Hold |
953,035
| – | – | 39.85% | 2 |
|
|
2019
Q4 | $16.6M | Hold |
953,035
| – | – | 19.87% | 2 |
|
|
2019
Q3 | $14.6M | Hold |
953,035
| – | – | 28.53% | 2 |
|
|
2019
Q2 | $19.8M | Hold |
953,035
| – | – | 29.05% | 2 |
|
|
2019
Q1 | $22.1M | Sell |
953,035
-158,764
| -14% | -$3.69M | 21.78% | 2 |
|
|
2018
Q4 | $23M | Buy |
+1,111,799
| New | +$23M | 24.06% | 2 |
|